Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Operating Expenses (2020 - 2025)

iSpecimen has reported Operating Expenses over the past 6 years, most recently at $9.2 million for Q4 2025.

  • Quarterly results put Operating Expenses at $9.2 million for Q4 2025, up 358.89% from a year ago — trailing twelve months through Dec 2025 was $17.4 million (up 29.27% YoY), and the annual figure for FY2025 was $10.9 million, up 94.93%.
  • Operating Expenses for Q4 2025 was $9.2 million at iSpecimen, up from $2.9 million in the prior quarter.
  • Over the last five years, Operating Expenses for ISPC hit a ceiling of $9.2 million in Q4 2025 and a floor of -$9.8 million in Q4 2023.
  • Median Operating Expenses over the past 5 years was $4.5 million (2021), compared with a mean of $3.7 million.
  • Biggest five-year swings in Operating Expenses: tumbled 291.93% in 2023 and later surged 358.89% in 2025.
  • iSpecimen's Operating Expenses stood at $4.5 million in 2021, then rose by 12.3% to $5.1 million in 2022, then tumbled by 291.93% to -$9.8 million in 2023, then surged by 120.46% to $2.0 million in 2024, then surged by 358.89% to $9.2 million in 2025.
  • The last three reported values for Operating Expenses were $9.2 million (Q4 2025), $2.9 million (Q3 2025), and $2.5 million (Q2 2025) per Business Quant data.